Literature DB >> 15241181

The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential.

Zhao Zhong Chong1, Shi-Hua Lin, Kenneth Maiese.   

Abstract

Nicotinamide, a beta-nicotinamide adenine dinucleotide (NAD) precursor and an essential nutrient for cell growth and function, may offer critical insights into the specific cellular mechanisms that determine neuronal survival, since this agent significantly impacts upon both neuronal and vascular integrity in the central nervous system. The authors show that nicotinamide provides broad, but concentration-specific, protection against apoptotic genomic DNA fragmentation and membrane phosphatidylserine exposure during oxidative stress to secure cellular integrity and prevent phagocytic cellular demise. Activation of the protein kinase B (Akt1) pathway is a necessary requirement for nicotinamide protection, because transfection of primary hippocampal neurons with a plasmid encoding a kinase-deficient dominant-negative Akt1 as well as pharmacologic inhibition of phosphatidylinositol-3-kinase phosphorylation of Akt1 eliminates cytoprotection by nicotinamide. Nicotinamide fosters neuronal survival through a series of intimately associated pathways. At one level, nicotinamide directly modulates mitochondrial membrane potential and pore formation to prevent cytochrome c release and caspase-3-and 9-like activities through mechanisms that are independent of the apoptotic protease activating factor-1. At a second level, nicotinamide maintains an inhibitory phosphorylation of the forkhead transcription factor FOXO3a at the regulatory sites of Thr and Ser and governs a unique regulatory loop that prevents the degradation of phosphorylated FOXO3a by caspase-3. Their work elucidates some of the unique neuro-protective pathways used by the essential cellular nutrient nicotinamide that may direct future therapeutic approaches for neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241181     DOI: 10.1097/01.WCB.0000122746.72175.0E

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  78 in total

1.  FoxO3a changes in pyramidal neurons and expresses in non-pyramidal neurons and astrocytes in the gerbil hippocampal CA1 region after transient cerebral ischemia.

Authors:  Ki-Yeon Yoo; Seung-Hae Kwon; Choong Hyun Lee; Bingchun Yan; Joon Ha Park; Ji Hyeon Ahn; Jung Hoon Choi; Taek Geun Ohk; Jun Hwi Cho; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-11-12       Impact factor: 3.996

2.  Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain.

Authors:  Najeeb Ullah; Ikram Ullah; Hae Young Lee; Muhammad Imran Naseer; Park Moon Seok; Jawad Ahmed; Myeong Ok Kim
Journal:  J Mol Neurosci       Date:  2011-12-08       Impact factor: 3.444

Review 3.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

4.  Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

5.  Serum or target deprivation-induced neuronal death causes oxidative neuronal accumulation of Zn2+ and loss of NAD+.

Authors:  Christian T Sheline; Ai-Li Cai; Julia Zhu; Chunxiao Shi
Journal:  Eur J Neurosci       Date:  2010-08-16       Impact factor: 3.386

6.  Vulnerability to a Metabolic Challenge Following Perinatal Asphyxia Evaluated by Organotypic Cultures: Neonatal Nicotinamide Treatment.

Authors:  R Perez-Lobos; C Lespay-Rebolledo; A Tapia-Bustos; E Palacios; V Vío; D Bustamante; P Morales; M Herrera-Marschitz
Journal:  Neurotox Res       Date:  2017-06-19       Impact factor: 3.911

Review 7.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

Review 8.  Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Brain Res Brain Res Rev       Date:  2005-01-08

Review 9.  Novel directions for diabetes mellitus drug discovery.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Expert Opin Drug Discov       Date:  2012-10-24       Impact factor: 6.098

Review 10.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.